<qa>  What type of monotherapy is currently receiving for at least 12 weeks?- Type 2 diabetics currently receiving a stable dose of TZD monotherapy pioglitazone 30mg or 45mg, or rosiglitazone 4mg or 8mg for at least 12 weeks prior to screening. 